about
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote ca...
Read More
8.18
-0.19
(-2.27%)
1.9M
XNAS Volume
XNAS 23 Sep, 2026 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution
View Similar
Embed DVM
Verastem Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..